4//SEC Filing
Murray Mark J. 4
Accession 0001140361-18-018863
CIK 0001447028other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 8:22 PM ET
Size
9.3 KB
Accession
0001140361-18-018863
Insider Transaction Report
Form 4
Murray Mark J.
DirectorPresident & CEO
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-04-16+418,187→ 418,187 totalExercise: $5.20Exp: 2028-04-16→ Common Stock (418,187 underlying) - Exercise/Conversion
Common Shares
2018-04-17$0.35/sh+27,007$9,560→ 316,396 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-04-17−27,007→ 0 totalExercise: $0.35From: 2008-03-30Exp: 2018-03-01→ Common Stock (27,007 underlying)
Footnotes (3)
- [F1]The options vest as follows: 1/3 on April 16, 2019; 1/3 on April 16, 2020; and 1/3 on April 16, 2021.
- [F2]Converted from Canadian exercise price of $0.4444; Cdn$1.2552=US$1.00.
- [F3]Expiration date extended through termination of blackout period.
Documents
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeother
Related Parties
1- filerCIK 0001628383
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 8:22 PM ET
- Size
- 9.3 KB